ScentRadar
Bujairami Affectionate Eau de Parfum bottle
Image: FragranceGems

Bujairami

Affectionate Bujairami for women and men

Main accords

Sweet & gourmand
Vanilla
Smoky & incense
Musky
Woody
Amber

Our estimate from the notes the brand lists, not a statement by the brand.

Your lists

Follow Bujairami AffectionateFollow Bujairami

About Affectionate

Affectionate is a perfume by Bujairami (Eau de Parfum, 100 ml, women and men). The brand names Caramel, Benzoin, Tonka Bean, Patchouli, Vanilla among its notes. We first saw it on the brand's website on 12 October 2026.

Notes pyramid

Notes as Bujairami lists them. Icons show our grouping into scent families.

What wearers say

No votes yet: be the first.

Longevity
Sillage
Season
Day or night
Feels

Layer it with Affectionate

All layering ideas

Our suggestions from the listed notes. Try them and vote.

Does it match your scent DNA?

Make your scent DNA in a minute and see how well this perfume fits you.

Make my scent DNA

Details

BrandBujairami
PerfumeAffectionate
ConcentrationEau de Parfum
Sizes100 ml
Forunisex
Scent familySweet & gourmand
First seen

Where to find it

FragranceGems, the publisher of this site, lists Affectionate: Affectionate at FragranceGems.

We never show prices. Availability can change; check the shop.

More from Bujairami

See all

New from Bujairami

Perfumes with similar notes

From the Arabian houses we follow, by shared notes.

Questions

What are the notes of Bujairami Affectionate?

Bujairami lists top notes of Caramel, Benzoin, heart notes of Tonka Bean, Patchouli and base notes of Vanilla, Labdanum, Musk.

What does Affectionate smell like?

Going by the notes the brand lists, Affectionate leans sweet & gourmand, vanilla and smoky & incense. This is our estimate from the notes, not a statement by the brand.

What concentration is Bujairami Affectionate?

Bujairami lists Affectionate as Eau de Parfum, in 100 ml.

Is Affectionate for men or women?

Bujairami presents Affectionate as unisex.

Impressions and reviews

Sort by

No reactions yet: write the first.